Cannara Biotech Inc. (TSX:LOVE)
Canada · Delayed Price · Currency is CAD 1.890
-0.030 (-1.56%)
Jul 20, 2026, 3:59 PM EST
Cannara Biotech Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, Cannara Biotech stock has a consensus rating of "Strong Buy" and an average price target of $3.38. The average 1-year stock price forecast is 78.84% higher than the current stock price, while the lowest is $3.00 (+58.73%) and the highest is $4.00 (+111.64%).
Price Target: $3.38 (+78.84%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cannara Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 3 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Atrium Research | Atrium Research | Buy Maintains $3.00 | Buy | Maintains | $3.00 | +58.73% | Jul 16, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $4.00 | Buy | Maintains | $4.00 | +111.64% | Jul 16, 2026 |
| Haywood | Haywood | Buy Reiterates $3.00 | Buy | Reiterates | $3.00 | +58.73% | Jul 15, 2026 |
Financial Forecast
Revenue This Year
123.32M
from 107.20M
Increased by 15.03%
Revenue Next Year
145.97M
from 123.32M
Increased by 18.37%
EPS This Year
0.12
from 0.14
Decreased by -14.29%
EPS Next Year
0.20
from 0.12
Increased by 69.44%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.